Sort
30,917 grants matching “tumor microenvironment”
Developmental pathways regulating adult lung quiescence
$568,206Edward E Morrisey · University Of Pennsylvania · R01 · FY2016 · HL
Detecting prostate cancer aggressiveness using photoacoustic chemical imaging with photoacoustic spectral analysis
$568,151Janggun Jo · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers
$568,123Ricardo Otazo · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Coordinating Center for Canine Immunotherapy Trials and Correlative Studies
$567,985Nicola J Mason · University Of Pennsylvania · U24 · FY2021 · CA
Matrix Organization and Dimensionality
$567,979Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2011 · DE
Intratumor co-delivery of DNA and RNA to relieve cancer pain
$567,884Brian L Schmidt · New York University · R01 · FY2024 · DE
Engineering In Vivo Chimeric Antigen Receptor Macrophages (CARMs) using mRNA-exosomes for Cancer Immunotherapy
$567,816Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer
$567,785Maneesh Jain · University Of Nebraska Medical Center · R01 · FY2021 · CA
Targeting Lipid Unsaturation in Ovarian Cancer Stem Cells
$567,557Daniela E Matei · Northwestern University At Chicago · R01 · FY2018 · CA
CAREER: In Vitro Model Approaches Leveraging Quantitative Cancer Cell Properties as Determinants of Metastatic Potential
$567,520Cheryl Gomillion · University Of Georgia Research Foundation Inc · · FY2022 · ENG
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy
$567,432Konstantin V Sokolov · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Mechanism of Activity of Lonidamine
$567,405Jerry D Glickson · University Of Pennsylvania · R01 · FY2013 · CA
Small molecule probes of MYC stability and function intumorigenesis
$567,361Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2021 · CA
Coordinating Center for Canine Immunotherapy Trials and Correlative Studies
$567,292Nicola J Mason · University Of Pennsylvania · U24 · FY2020 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$567,204Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2024 · CA
Ecology and Evolution of Breast Carcinogenesis
$567,165Mehdi Damaghi · State University New York Stony Brook · U01 · FY2024 · CA
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
$567,157Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Multidimensional analyses to improve PSMA-RPT efficacy in mCRPC
$567,087Johannes Czernin · University Of California Los Angeles · R01 · FY2024 · CA
Endogenous Circular RNAs limit abemaciclib anti tumor immune responses
$567,059Jlenia Guarnerio · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Project 3: Combinatorial and gene-editing approaches to enhance the efficacy of CAR T cell therapy of multiple myeloma.
$567,040Edward A Stadtmauer · University Of Pennsylvania · P01 · FY2021 · CA
Chemokine interaction with CXCR4 and ACKR3: structure and activation mechanisms
$567,004Tracy M Handel · University Of California, San Diego · R01 · FY2016 · GM
Pathogenesis of the cART unresponsive Kaposiâs sarcoma tumor niche
$566,972Michael Shannon McGrath · University Of California, San Francisco · R01 · FY2022 · CA
Pathogenesis of the cART unresponsive Kaposiâs sarcoma tumor niche
$566,972Michael Shannon McGrath · University Of California, San Francisco · R01 · FY2021 · CA
Pathogenesis of the cART unresponsive Kaposiâs sarcoma tumor niche
$566,972Michael Shannon McGrath · University Of California, San Francisco · R01 · FY2020 · CA
Pathogenesis of the cART unresponsive Kaposiâs sarcoma tumor niche
$566,972Michael Shannon McGrath · University Of California, San Francisco · R01 · FY2023 · CA